PHASE II TRIALS OF TRIMETREXATE IN ADVANCED ADULT SOFT-TISSUE SARCOMA - STUDIES OF THE CANADIAN-SARCOMA-GROUP AND THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP

被引:13
|
作者
EISENHAUER, EA
WIERZBICKI, R
KNOWLING, M
BRAMWELL, VHC
QUIRT, IC
机构
[1] PRINCESS MARGARET HOSP, TORONTO M4X 1K9, ONTARIO, CANADA
[2] LONDON REG CANC CTR, LONDON, ONTARIO, CANADA
[3] NOVA SCOTIA CANC TREATMENT & RES FDN, HALIFAX, NS, CANADA
关键词
PHASE-II TRIAL; TRIMETREXATE; SOFT TISSUE SARCOMA;
D O I
10.1093/oxfordjournals.annonc.a058051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:689 / 690
页数:2
相关论文
共 50 条
  • [1] PHASE-II TRIAL TO 10-EDAM IN ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE CANADIAN SARCOMA GROUP AND THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    KNOWLING, M
    BRAMWELL, V
    EISENHAUER, E
    BOOS, G
    BODURTHA, A
    QUIRT, I
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (08) : 766 - 768
  • [2] TESTING HYPOTHESES IN CLINICAL-TRIALS - EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    PATER, JL
    EISENHAUER, E
    SHELLEY, W
    WILLAN, AR
    [J]. CANCER TREATMENT REPORTS, 1986, 70 (09): : 1133 - 1136
  • [3] PHASE-II STUDY OF TRIMETREXATE IN MALIGNANT-MELANOMA - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    ISCOE, NA
    EISENHAUER, EA
    BODURTHA, AJ
    [J]. INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 121 - 123
  • [4] PHASE-II STUDY OF TRIMETREXATE IN RECURRENT ANAPLASTIC GLIOMA - NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    CAIRNCROSS, JG
    EISENHAUER, EA
    MACDONALD, DR
    RATHBONE, MP
    MOORE, MJ
    SAWKA, CA
    MACCORMICK, RE
    KERR, IG
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (01) : 21 - 23
  • [5] PHASE-II STUDY OF MITOXANTRONE IN PATIENTS WITH MESOTHELIOMA - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    EISENHAUER, EA
    EVANS, WK
    RAGHAVAN, D
    DESMEULES, MJ
    MURRAY, NR
    STUARTHARRIS, R
    WILSON, KS
    [J]. CANCER TREATMENT REPORTS, 1986, 70 (08): : 1029 - 1030
  • [6] CLINICAL COOPERATIVE TRIALS OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS-GROUP BREAST-CANCER-SITE-GROUP
    PRITCHARD, KI
    [J]. CANCER, 1994, 74 (03) : 1150 - 1155
  • [7] REVIEW OF THE CLINICAL-TRIALS ACTIVITY OF THE SOFT-TISSUE AND BONE SARCOMA GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER
    BRAMWELL, VHC
    SANTORO, A
    ROUESSE, J
    MOURIDSEN, H
    STEWARD, W
    VANOOSTEROM, A
    SOMERS, R
    BUESA, J
    MULDER, J
    SCHUTTE, J
    PINEDO, H
    BLACKLEDGE, G
    WAGENER, T
    DOMBERNOWKY, P
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01): : 45 - 52
  • [8] PHASE-II STUDY OF CARBOPLATIN IN PATIENTS WITH OVARIAN-CARCINOMA - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    EISENHAUER, EA
    SWENERTON, KD
    STURGEON, JFG
    FINE, S
    OREILLY, SE
    [J]. CANCER TREATMENT REPORTS, 1986, 70 (10): : 1195 - 1198
  • [9] A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial
    M. Knowling
    M. Blackstein
    R. Tozer
    V. Bramwell
    J. Dancey
    N. Dore
    S. Matthews
    E. Eisenhauer
    [J]. Investigational New Drugs, 2006, 24 : 435 - 439
  • [10] A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial
    Knowling, M
    Blackstein, M
    Tozer, R
    Bramwell, V
    Dancey, J
    Dore, N
    Matthews, S
    Eisenhauer, E
    [J]. INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) : 435 - 439